|Bid||1.1300 x 1039400|
|Ask||1.1500 x 480500|
|Day's range||1.1000 - 1.1500|
|52-week range||0.7150 - 1.3500|
|Beta (5Y monthly)||0.88|
|PE ratio (TTM)||N/A|
|Earnings date||22 Feb 2023 - 27 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.77|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to announce it has assembled a team of world leading clinicians specialising in nephrology and endocrinology to advise the Company on its clinical and commercial initiatives towards a successful launch of the PromarkerD test for diabetic kidney disease to physicians globally.
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...